Targeting rage/DIAPH1: novel therapeutic strategy for diabetic complications

Ended Project Grant Awarded Last action

Award ID
R01DK122456
Recipient
Awarding agency
Obligated
$6,179,152

Award facts

Completion date
Originally
Funding
  • $5,542,555.79 Federal
  • $636,596.00 Non-federal
Place of performance
New York, NY 10016, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$117 $0
Amendment $36,506 $0
Amendment $547,607 $0
Amendment $547,607 $0
Amendment $615,294 $0
Amendment $615,294 $0
Amendment $615,294 $0
Amendment $619,879 $0
Amendment $0 $0
Amendment $0 $0
Amendment $636,596 $0
Amendment $636,596 $636,596
Amendment $0 $0
Amendment $0 $0
Original award $672,000 $0
Show all 15

Subawards

Subrecipient Amount Awarded
State University Of New York Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications $57,715
Weill Medical College Of Cornell University $12,460

Quick answers

Who received award R01DK122456?

R01DK122456 was awarded to New York University by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on July 1, 2020.

How much is award R01DK122456 worth?

$6,179,152 has been obligated on R01DK122456: $5,542,556 in federal funding and $636,596 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award